日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Algor-Ethics in Diabetes Care: Mapping the Route

糖尿病护理中的算法伦理:规划路径

Bemporad, Joshua; De Domenico, Francesco; Pozzilli, Paolo

C-peptide as an important biomarker in diabetes management: The need for standardization of its measurement

C肽作为糖尿病管理中的重要生物标志物:亟需对其测量方法进行标准化。

Kabytaev, Kuanysh; Maddaloni, Ernesto; Ferm, Michael L; Redondo, Maria J; Buzzetti, Raffaella; Pozzilli, Paolo

Metabolic Cardiovascular Renal Disease (Met-CVRD): A New Nomenclature

代谢性心血管肾脏疾病(Met-CVRD):一种新的命名法

Pozzilli, Paolo; Messina, Maria Vittoria; Roden, Michael

Beyond inflammation: the multifaceted therapeutic potential of targeting the CXCL8-CXCR1/2 axis in type 1 diabetes

超越炎症:靶向 CXCL8-CXCR1/2 轴在 1 型糖尿病治疗中的多方面潜力

Fousteri, Georgia; Jones, Meghan; Novelli, Rubina; Boccella, Serena; Brandolini, Laura; Aramini, Andrea; Pozzilli, Paolo; Allegretti, Marcello

IFN-α Neutralizing Antibodies Distinguish LADA From Early-onset Type 1 Diabetes

IFN-α中和抗体可区分LADA和早发型1型糖尿病

Amendolara, Rocco; D'Onofrio, Luca; Sessa, Rosario Luigi; Di Giulio, Stefano; Mignogna, Carmen; Coraggio, Lucia; Schirano, Roberto; Zampetti, Simona; Malandrucco, Ilaria; Pozzilli, Paolo; Giannini, Giuseppe; Maddaloni, Ernesto; Buzzetti, Raffaella

Perspectives on Artificial Intelligence in Medical Publishing: A Survey of Medical Journal Editors

医学出版业对人工智能的看法:一项针对医学期刊编辑的调查

Biondi-Zoccai, Giuseppe; Lauretti, Attilio; Agewall, Stefan; Andres, Emmanuel; Audisio, Riccardo A; Bhatt, Deepak L; Citerio, Giuseppe; Drezner, Jonathan A; Eggermont, Alexander; Erol, Cetin; Ersche, Karen D; Ferriero, Giorgio; Heusch, Gerd; Indolfi, Ciro; Insel, Paul A; Lavie, Carl J; La Vecchia, Carlo; Maffulli, Nicola; Montecucco, Fabrizio; Moliterno, David J; Nattel, Stanley; O'Kane, Peter; Oliaro, Elena; Pelliccia, Antonio; Picard, Michael; Pozzilli, Paolo; Quaglia, Fabiana; Riha, Renata L; Sarkar, Rupa; Scicchitano, Pietro; Teboul, Jean-Louis; Stahel, Hendrik Tevaearai; Wold, Loren E; Booz, George W

Cardio-renal-metabolic disease in primary care setting

初级保健机构中的心肾代谢疾病

Ibrahim, Mahmoud; Ba-Essa, Ebtesam M; Baker, Jason; Cahn, Avivit; Ceriello, Antonio; Cosentino, Francesco; Davies, Melanie J; Eckel, Robert H; Van Gaal, Luc; Gaede, Peter; Handelsman, Yehuda; Klein, Samuel; Leslie, Richard David; Pozzilli, Paolo; Del Prato, Stefano; Prattichizzo, Francesco; Schnell, Oliver; Seferovic, Petar M; Standl, Eberhard; Thomas, Abraham; Tuomilehto, Jaakko; Valensi, Paul; Umpierrez, Guillermo E

Autoantibody and T cell responses to oxidative post-translationally modified insulin neoantigenic peptides in type 1 diabetes.

1 型糖尿病中针对氧化后翻译修饰的胰岛素新抗原肽的自身抗体和 T 细胞反应

Strollo Rocky, Vinci Chiara, Man Y K Stella, Bruzzaniti Sara, Piemonte Erica, Alhamar Ghadeer, Briganti Silvia Irina, Malandrucco Ilaria, Tramontana Flavia, Fanali Chiara, Garnett James, Buccafusca Roberto, Guyer Perrin, Mamula Mark, James Eddie A, Pozzilli Paolo, Ludvigsson Johnny, Winyard Paul G, Galgani Mario, Nissim Ahuva

Prevaccination Glucose Time in Range Correlates With Antibody Response to SARS-CoV-2 Vaccine in Type 1 Diabetes.

1 型糖尿病患者接种 SARS-CoV-2 疫苗前血糖达标时间与抗体反应相关

Alhamar Ghadeer, Briganti Silvia, Maggi Daria, Viola Viola, Faraj Malak, Zannella Carla, Galdiero Massimiliano, Franci Gianluigi, Fusco Clorinda, Isgrò Camilla, Leanza Giulia, Malandrucco Ilaria, Spinelli Andrea, Tramontana Flavia, Iaria Domenico, Tortoriello Rachele, Pieralice Silvia, Rosati Milena, Matarese Giuseppe, Pozzilli Paolo, Galgani Mario, Strollo Rocky

Post hoc analysis of a randomized, double-blind, prospective trial evaluating a CXCR1/2 inhibitor in new-onset type 1 diabetes: endo-metabolic features at baseline identify a subgroup of responders

对一项评估 CXCR1/2 抑制剂治疗新发 1 型糖尿病的随机、双盲、前瞻性试验进行事后分析:基线时的内代谢特征可识别出应答者亚组

Sordi, Valeria; Monti, Paolo; Lampasona, Vito; Melzi, Raffaella; Pellegrini, Silvia; Keymeulen, Bart; Gillard, Pieter; Linn, Thomas; Bosi, Emanuele; Rose, Ludger; Pozzilli, Paolo; Giorgino, Francesco; Cossu, Efisio; Piemonti, Lorenzo